Author

Kazuhiro Yatera

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis.

OBJECTIVES To evaluate the effectiveness and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in rheumatoid arthritis (RA)-associated progressive pulmonary fibrosis (PPF). METHODS Real-world data were retrospectively collected in RA-associated PPF during the first year after bDMARD initiation. The...

R. Kanda, Yoshiya Tanaka, Y. Miyazaki et al. · Rheumatology · 0 citations

Open access Sep 2026

OSU-03012 mitigates pulmonary fibrosis by targeting ECM proteins via suppression of S6K-mediated translation and acceleration of MMP-driven clearance.

Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disease. Currently available anti-fibrotic therapies are limited to slowing lung function decline; however, inducing the resolution of fibrotic lesions remains highly challenging. This study investigated the anti-fibrotic potential and underlying molecular mec...

Kohei Hashimoto, Masaki Arioka, Toshiki Morimoto et al. · Biomedicine & pharmacotherap... · 0 citations

Open access Jul 2026

Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema.

BACKGROUND AND OBJECTIVE Combined pulmonary fibrosis and emphysema (CPFE) is characterized by coexisting upper-zone emphysema and lower-zone fibrosis, but standardized diagnostic criteria and clinical outcomes remain poorly defined. This study aimed to evaluate survival, acute exacerbation incidence, and disease progre...

K. Tsubouchi, Y. Kotetsu, Tomotsugu Takano et al. · Respirology (Carlton South.... · 0 citations